cyc 202 has been researched along with Astrocytoma, Grade IV in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kilbride, SM; Kögel, D; Letai, AG; Loh, KP; Murphy, ÁC; Murphy, BM; Noonan, J; Prehn, JH; Schimansky, S; Weyhenmeyer, B | 1 |
| Di Fazio, P; Goetz, C; Kolodziej, M; Montalbano, R; Ocker, M; Quint, K; Strik, H | 1 |
| Boethius, J; Cruz, MH; Lindblom, IO; Sidén, A; Vargas, VI; Wallstedt, L; Yakisich, JS | 1 |
1 trial(s) available for cyc 202 and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Inhibition of DNA synthesis in human gliomas by roscovitine.
Topics: Adult; Antineoplastic Agents; DNA, Neoplasm; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Proteins; Purines; Roscovitine | 1999 |
2 other study(ies) available for cyc 202 and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Caspase 3; Caspase 8; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Gene Silencing; Glioblastoma; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Purines; Roscovitine; TNF-Related Apoptosis-Inducing Ligand | 2014 |
Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: A pilot study.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Neoplasm Proteins; Purines; Roscovitine | 2015 |